Welcome to our dedicated page for American Diversified news (Ticker: ADHC), a resource for investors and traders seeking the latest updates and insights on American Diversified stock.
American Diversified Holdings Corporation (OTC Pink: ADHC) generates news primarily through its work on GlucoGuard, a patent-pending nocturnal glucose monitoring and delivery system for diabetic patients. Company updates focus on technology development, regulatory interactions, partnerships, capital formation, and related initiatives that shape the trajectory of this medical device project.
Readers following ADHC news can expect detailed announcements about GlucoGuard's progress with the U.S. Food and Drug Administration, including the Breakthrough Device Application process and feedback from FDA reviewers. Releases also describe prototype development plans, early feasibility study preparation, and the incorporation of FDA recommendations into device design and engineering work.
ADHC news frequently highlights collaborations with external partners. These include a university-based program supporting app and algorithm development, a bioengineering firm engaged in device design and prototyping, and integration efforts with a continuous glucose monitoring company through its developer program and API. Updates often cover milestones such as app integration levels, predictive algorithm performance, and CAD design stages for the device.
In addition to GlucoGuard-specific items, ADHC issues news about strategic and financial developments. Examples include issuer-sponsored research coverage and valuation analysis, funding commitments to support GlucoGuard development, a strategic alliance with a technology and cybersecurity firm focused on AI-driven projects, and the company’s Digital Asset Treasury purchase of OTCfi tokens. Together, these topics provide a view into both the operational and corporate aspects of ADHC.
This news page brings these company communications into one place, allowing investors and observers to review ADHC’s ongoing disclosures about GlucoGuard, its partnerships, and its broader strategic initiatives.
American Diversified Holdings (OTC Pink: ADHC) has appointed Dr. Stephen C. Weber, MD to lead its Medical Advisory Board. Dr. Weber is currently an Assistant Professor at Johns Hopkins School of Medicine and previously served as a Medical Officer and Clinical Reviewer at the FDA. With over 25 years of experience as an Orthopaedic Surgeon, Dr. Weber will lead the development of Glucoguard and help identify additional acquisition opportunities for the company.
American Diversified Holdings (ADHC) announced that its division, Glucoguard, has completed the Mobile Application and Design Outline (MADO) for Dexcom API Integration. The outline features a proprietary AI-based algorithm that forms the backbone of the Glucoguard App, designed to analyze blood sugar levels and predictively treat lows before hypoglycemic events occur.
The system integrates with Dexcom's Continuous Glucose Monitoring (CGM) technology to track glucose levels in real-time. The mobile app will connect users to the Glucoguard device, which delivers glucose when the AI algorithm detects critical changes, preventing dangerous episodes of hypoglycemia. The company will proceed with prototype development and full software/hardware integration once API integration is complete.
American Diversified Holdings (ADHC) has completed the acquisition of GlucoGuard, an AI-driven medical device technology from IMD Solutions. GlucoGuard is designed to manage nocturnal hypoglycemia in diabetic patients through non-invasive, continuous glucose monitoring and delivery. The acquisition terms are undisclosed, but financing is expected to be non-dilutive.
Key developments include:
- Elimination of $2.7 million in corporate debt
- 144 million share cancellation in progress
- Filed fiscal year-end financials
- Global distribution of corporate information
GlucoGuard's founder, Zachary Smith, will join ADHC's advisory board. The technology is being developed in collaboration with a leading U.S. research university, a biomedical and defense engineering firm, and a top publicly traded company in the CGM sector.
American Diversified Holdings (ADHC) has announced the acquisition of GlucoGuard, an AI-driven medical device technology from IMD Solutions. GlucoGuard is designed to manage nocturnal hypoglycemia in diabetic patients through non-invasive, continuous glucose monitoring and delivery. The acquisition's terms are undisclosed, with financing expected to be non-dilutive.
GlucoGuard's founder, Zachary Smith, will join ADHC's advisory board alongside Bill Colone. The technology is being developed in partnership with a leading U.S. research university, a biomedical and defense engineering firm, and a top publicly traded company in the Continuous Glucose Monitoring sector.
The GlucoGuard system combines advanced engineering, AI, and mobile app-based monitoring to create an innovative solution for managing nocturnal hypoglycemia, addressing a critical challenge in diabetes care.
American Diversified Holdings (OTC Pink: ADHC) has announced the completion of a comprehensive overhaul of its balance sheet and capitalization structure. The company has identified an additional 142 million shares of common stock to be cancelled and returned to the Corporate Treasury, bringing the total cancellation to over 466 million shares. This follows a recent $2.73 million debt cancellation and a court order from the Eighth Judicial Circuit Court, Clark County, Nevada, for the cancellation of 324.5 million shares.
ADHC management stated that these actions will solidify the company's capitalization structure as they contemplate new business operations and potential acquisitions. The company has established a shareholder hotline and direct IR email for investor communication. ADHC is focusing on building for future success and plans to publicize future developments in the near term.
American Diversified Holdings (OTC Pink: ADHC) has announced a major debt restructuring, eliminating $2,726,729.00 in debt from their balance sheet. This move will render ADHC debt-free, significantly strengthening its market position. The debt elimination is expected to be reflected in the corporate annual report due September 30, 2024.
ADHC management stated that this restructuring makes the company a more attractive partner for potential business relationships and acquisitions. The company's operational division, Universal Wellness AI, is actively seeking such opportunities. ADHC has conducted a thorough review of its capital structure, including the stock table and balance sheet, in collaboration with attorneys and auditors.
The company plans to announce further corporate actions and developments in the near future as it continues to build for success.
American Diversified Holdings (OTC Pink: ADHC) has launched a new AI-focused business division, Universal Wellness AI (www.UniversalWellnessAI.com). The platform integrates AI technology into patient wellness and preventative healthcare, featuring AI avatars and a ChatGPT customer service module. It focuses on four areas: treatment modalities, AI algorithms for health predictions, biodevice innovations, and app-based connectivity.
The initiative is supported by industry professionals, including Bill Colone (biodevice engineer) and Melissa Dugan (founder of Pharmstrong). The global health and wellness market is projected to reach $12.9 trillion by 2031, growing at a CAGR of 10.9%. Meanwhile, the global AI market is expected to grow from $621.19 billion in 2024 to $2,740.46 billion by 2032, with a CAGR of 20.4%.
American Diversified Holdings (OTC Pink: ADHC) announced the appointment of Bill Colone as an advisor for entry into the $585 billion bio device market. Colone, with over 40 years of experience and 13 US patents, has successfully guided companies through the FDA approval process. Currently, he holds senior roles at Med Edge Innovations, Indian Wells Medical, and is CEO of Single Pass, Inc., which recently received FDA approval for an electrocautery device. Colone aims to create shareholder value through acquisitions or strategic alliances.
ADHC Completes Acquisition of Rolls Choice™
American Diversified Holdings Corporation (OTC: ADHC) has announced the acquisition of southern California-based cannabis firm Rolls Choice™. This transaction aims to enhance ADHC’s product line, particularly the Cannabis Adhesive Glue Pen, with additional funding to support inventory and marketing efforts. Rolls Choice™ boasts over 80,000 social media followers, contributing to brand visibility. The acquisition is projected to pave the way for new business initiatives and potential celebrity endorsements as ADHC strives for substantial growth in 2023.
American Diversified Holdings Corporation (ADHC) has announced the formation of a Scientific Advisory Board to enhance its acquisition and management transition efforts, as detailed in a recent press release dated December 15, 2022. The company has filed its first quarter financial disclosures for the period ending October 31, 2022. Currently, ADHC has 1.028 billion shares outstanding, including 522 million restricted shares. A lawsuit has been filed to cancel 324 million shares, with expectations of a ruling soon. The company is also developing three web-based businesses focused on wellness and lifestyle.
FAQ
What is the current stock price of American Diversified (ADHC)?
What is the market cap of American Diversified (ADHC)?
